1 Min Read
Oct 26 (Reuters) - JCR Pharmaceuticals Co Ltd
* Says it will initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo
Source text in Japanese:goo.gl/59TXUt
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.